Why investors just bet $85M on this Indian company’s generic drug strategy

Truemeds, an Indian online pharmacy startup, has raised $85 million in funding, indicating investors' confidence in its generic drug strategy. Unlike other Indian online pharmacies, Truemeds has focused on offering affordable generic drugs, which has helped the company double its revenue. The startup's approach of providing access to quality generic medicines at lower prices has resonated with customers, leading to its rapid growth. Truemeds has leveraged technology to streamline its operations, ensuring efficient drug procurement, storage, and delivery. The funding will enable Truemeds to expand its reach, enhance its technology infrastructure, and diversify its product offerings. The company aims to further strengthen its position in the Indian healthcare market by catering to the growing demand for affordable and accessible generic drugs. The success of Truemeds' generic drug strategy highlights the potential for innovative solutions to address healthcare challenges in India, where access to affordable medicines remains a significant concern for many people.